{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:50:55Z","timestamp":1761173455927,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.purol.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T08:42:47Z","timestamp":1321692167000},"page":"284-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Atteinte de la Muscularis Mucosae dans les tumeurs uroth\u00e9liales T1\u00a0de vessie\u00a0: facteur pronostique de progression apr\u00e8s immunoth\u00e9rapie par BCG"],"prefix":"10.1016","volume":"22","author":[{"given":"Y.","family":"Nguyen-Huu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lillaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bedgedjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Le Ray-Ferri\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chabannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bittard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kleinclauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2011.10.002_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2011.10.002_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin\u00a0C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","article-title":"Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer?. A meta-analysis of randomized trials","volume":"67","author":"Han","year":"2006","journal-title":"Urology"},{"issue":"Suppl. 4","key":"10.1016\/j.purol.2011.10.002_bib0025","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/S1166-7087(10)70043-9","article-title":"Recommendations onco-urology\u00a02010: urothelial tumors","volume":"20","author":"Pfister","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0030","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of non muscle invasive bladder cancer (stages\u00a0Ta, T1, and Tis): 2007\u00a0update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0045","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005392-200101000-00011","article-title":"The predictive value of muscularis mucosae invasion and p53\u00a0over expression on progression of stage\u00a0T1\u00a0bladder carcinoma","volume":"165","author":"Bernardini","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0090-4295(98)00374-4","article-title":"Microstaging of pT1\u00a0transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression","volume":"52","author":"Smits","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.purol.2011.10.002_bib0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R","article-title":"The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder","volume":"66","author":"Younes","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2011.10.002_bib0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.purol.2010.02.002","article-title":"T1\u00a0bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a\/T1b). A multicenter study by the French Urological Association (CCAFU)","volume":"20","author":"Faivre d\u2019Arcier","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.urology.2006.09.019","article-title":"Long-term follow-up of patients with stage T1\u00a0high-grade transitional cell carcinoma managed by Bacille Calmette-Guerin immunotherapy","volume":"69","author":"Margel","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.purol.2011.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(05)67706-3","article-title":"Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade\u00a0T1\u00a0transitional cell carcinoma","volume":"163","author":"Kondylis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1\u00a0urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0085","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA. T1\u00a0and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2011.10.002_bib0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0090-4295(00)01117-1","article-title":"Tolerability of bacille Calmette-Guerin maintenance therapy for superficial bladder cancer","volume":"57","author":"Saint","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.purol.2011.10.002_bib0095","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708711002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708711002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:21:28Z","timestamp":1761114088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708711002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1166708711002909"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2011.10.002","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteinte de la Muscularis Mucosae dans les tumeurs uroth\u00e9liales T1\u00a0de vessie\u00a0: facteur pronostique de progression apr\u00e8s immunoth\u00e9rapie par BCG","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}